Area of research
Molecular Biology · Emergency Medicine
Research interest
Research interests include Gut microbiota and health, HIV-related health complications and treatments, HIV Research and Treatment, and COVID-19 Clinical Research Studies.
Long-term HIV-1 remission achieved through allogeneic haematopoietic stem cell transplant from a CCR5Δ32/Δ32 sibling donor.
Disruption of the Host-Microbiota-Vitamin B6 Tryptophan Axis in Acute COVID-19 and Persistent Pulmonary Impairment
Host Plasma Microenvironment in Immunometabolically Impaired HIV Infection Leads to Dysregulated Monocyte Function and Synaptic Transmission <i>Ex Vivo</i>
Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial
Cytomegalovirus Antibodies and Coronary Artery Disease in People with HIV: A Cohort Study.
Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity.
Gut Microbiota Alterations and Circulating Imidazole Propionate Levels Are Associated With Obstructive Coronary Artery Disease in People With HIV
Chronic HIV Infection Increases Monocyte NLRP3 Inflammasome-Dependent IL-1α and IL-1β Release.
The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis.
Viral, Host Factors or Both as COVID-19 Biomarkers.
IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement.
Author Correction: Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancer.
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancer.
Coronary Artery Disease in Persons With Human Immunodeficiency Virus Without Detectable Viral Replication
Fatty Acids Composition and HIV Infection: Altered Levels of n-6 Polyunsaturated Fatty Acids Are Associated with Disease Progression.
Phenylacetylglutamine From the Gut Microbiota: A Future Therapeutic Target in Heart Failure?
Neutrophil count predicts clinical outcome in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial.
Persistent T-cell exhaustion in relation to prolonged pulmonary pathology and death after severe COVID-19: Results from two Norwegian cohort studies.
Remdesivir modifies interferon response in hospitalized COVID-19 patients.
Microbiome-Derived Cobalamin and Succinyl-CoA are Powerful Biomarkers for Improved Screening of Anal Cancer
CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19.
Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.
Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement.
Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections.
Gut Leakage Markers in Response to Strenuous Exercise in Patients with Suspected Coronary Artery Disease.
Gut microbiota alterations in patients with persistent respiratory dysfunction three months after severe COVID-19
Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
Gut microbiota diversity predicts immune status in HIV-1 infection